ESG Clarity Committee

ESG Clarity Committee

Pharmaceuticals remain a draw for ESG investors

EdenTree's Patel says industry's response to Covid and innovation keep it attractive to ESG investors

ESG Clarity Committee

Four actions investors can take against human rights abuses

ESG Clarity Committee

Regulating data will not solve sustainability challenges

ESG Clarity Committee

Three ‘climate sinners’ expected to transition

ESG Clarity Committee

Funds must show how they meet their ESG objectives

ESG Clarity Committee

HSBC’s Kirk got a few things right

ESG Clarity Committee

Modern slavery: Every company ceasing business with Russia must examine their exposure

ESG Clarity Committee

Be open with clients about divesting from Russia

Search ESG Clarity

ESG Clarity Committee

Climate and stewardship practices lacking at investment firms

LCP survey finds encouraging focus on responsible investing across firms, but improvement needed in some areas

ESG Clarity Committee

Assessing company earning power and value post-COP26

ESG Clarity Committee

Tackling taboos: Steel, nuclear and concrete

Opinion

‘Enabling’ investment into healthy supply chains

Macro

2021: Building back better – The role of the investor

Opinion

Covid-19 underlines the need for harmony but risks fuelling discord

Opinion

Improving diversity; improving returns

Opinion

Pension schemes and members: Finding the common ground on ESG